Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

COPD as a systemic disease.

Alvar Agusti1, Joan B Soriano

  • 1Fundación Caubet-CIMERA Illes Balears, Mallorca, Spain. aagusti@hsd.es

COPD
|April 17, 2008
PubMed
Summary
This summary is machine-generated.

Chronic obstructive pulmonary disease (COPD) affects more than just the lungs. Systemic effects like weight loss and heart disease are common and linked to inflammation, requiring screening and management.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical impact of mucus plugs in bronchiectasis.

Scientific reports·2026
Same author

How artificial intelligence could improve the diagnosis and management of COPD: a perspective from GOLD.

American journal of respiratory and critical care medicine·2026
Same author

A Brief History of COPD: As Told by Some of Its Senior Scientists and Clinicians.

Journal of clinical medicine·2026
Same author

Astegolimab for COPD With Frequent Exacerbations: Pooled Analysis of the ALIENTO and ARNASA Trials.

American journal of respiratory and critical care medicine·2026
Same author

Safety and efficacy of astegolimab for COPD with frequent exacerbations regardless of baseline blood eosinophil counts (ALIENTO and ARNASA): randomised, double-blind, placebo-controlled, phase 2b and 3 trials.

Lancet (London, England)·2026
Same author

Radiomic analysis of computed tomography scans in COPD patients relates to different clinical and biological features, and identifies different lung function trajectories during follow-up.

ERJ open research·2026
Same journal

Global, Regional, and National Burden of COPD Attributable to Secondhand Smoke from 1990 to 2021: Findings from the Global Burden of Disease Study 2021.

COPD·2026
Same journal

Upregulation of LncRNA MIR31HG in COPD Correlates with Disease Severity and Facilitates Inflammation via miR-342-3p.

COPD·2026
Same journal

Methodological Considerations in the Development of the AECOPD "Infection Score".

COPD·2026
Same journal

Barriers and Facilitators to Treatment Plan Adoption and Self-Management in People with Chronic Obstructive Pulmonary Disease (COPD): A Systematic Search and Narrative Synthesis.

COPD·2026
Same journal

Airway Mucus Occlusions in Ex-Smokers with and Without COPD.

COPD·2026
Same journal

Symptom Improvement with BDP/FF/G Fixed Triple Inhalation Powder in Moderate to Severe COPD Patients Uncontrolled with Dual Therapies: A Non-Interventional, Open-Label, Single-Arm, Prospective Study (RESPONSE Slovenia).

COPD·2026
See all related articles

Area of Science:

  • Pulmonary Medicine
  • Systemic Inflammation Research

Background:

  • Chronic obstructive pulmonary disease (COPD) is a global health issue.
  • Traditionally viewed as solely a respiratory illness, COPD also presents with significant systemic effects.
  • These extra-pulmonary manifestations impact patient prognosis and well-being.

Purpose of the Study:

  • To highlight the systemic effects of COPD beyond the lungs.
  • To emphasize the role of chronic systemic inflammation in COPD's extra-pulmonary manifestations.
  • To advocate for systematic screening and management of these systemic effects.

Main Methods:

  • Review of current literature on COPD systemic effects.
  • Analysis of the role of low-grade chronic systemic inflammation.
  • Discussion of clinical implications for patient care.

Related Experiment Videos

Main Results:

  • COPD is associated with unintentional weight loss, skeletal muscle dysfunction, cardiovascular disease, osteoporosis, and depression.
  • Low-grade, chronic systemic inflammation is a key mechanism driving these systemic effects.
  • These manifestations are prevalent and significantly affect patient outcomes.

Conclusions:

  • Systemic effects are integral to the COPD experience.
  • Chronic inflammation links pulmonary and extra-pulmonary aspects of COPD.
  • Proactive screening and management of systemic manifestations are crucial for optimal COPD patient care.